These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21750869)

  • 1. Leptin enhances migration of human papillary thyroid cancer cells through the PI3K/AKT and MEK/ERK signaling pathways.
    Cheng SP; Yin PH; Hsu YC; Chang YC; Huang SY; Lee JJ; Chi CW
    Oncol Rep; 2011 Nov; 26(5):1265-71. PubMed ID: 21750869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells.
    Saxena NK; Sharma D; Ding X; Lin S; Marra F; Merlin D; Anania FA
    Cancer Res; 2007 Mar; 67(6):2497-507. PubMed ID: 17363567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological suppression of the Ras/MAPK pathway in thyroid carcinoma cells can provoke opposite effects on cell migration and proliferation: The appearance of yin-yang effects and the need of combinatorial treatments.
    Glassmann A; Winter J; Kraus D; Veit N; Probstmeier R
    Int J Oncol; 2014 Dec; 45(6):2587-95. PubMed ID: 25269412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combretastatin A4 Regulates Proliferation, Migration, Invasion, and Apoptosis of Thyroid Cancer Cells via PI3K/Akt Signaling Pathway.
    Liang W; Lai Y; Zhu M; Huang S; Feng W; Gu X
    Med Sci Monit; 2016 Dec; 22():4911-4917. PubMed ID: 27966519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways.
    Chen C; Chang YC; Lan MS; Breslin M
    Int J Oncol; 2013 Mar; 42(3):1113-9. PubMed ID: 23354006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-cadherin promotes thyroid tumorigenesis through modulating major signaling pathways.
    Da C; Wu K; Yue C; Bai P; Wang R; Wang G; Zhao M; Lv Y; Hou P
    Oncotarget; 2017 Jan; 8(5):8131-8142. PubMed ID: 28042956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin-R and its association with PI3K/AKT signaling pathway in papillary thyroid carcinoma.
    Uddin S; Bavi P; Siraj AK; Ahmed M; Al-Rasheed M; Hussain AR; Ahmed M; Amin T; Alzahrani A; Al-Dayel F; Abubaker J; Bu R; Al-Kuraya KS
    Endocr Relat Cancer; 2010 Mar; 17(1):191-202. PubMed ID: 20008098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet derived growth factor receptor alpha mediates nodal metastases in papillary thyroid cancer by driving the epithelial-mesenchymal transition.
    Ekpe-Adewuyi E; Lopez-Campistrous A; Tang X; Brindley DN; McMullen TP
    Oncotarget; 2016 Dec; 7(50):83684-83700. PubMed ID: 27845909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miRNA‑148a inhibits cell growth of papillary thyroid cancer through STAT3 and PI3K/AKT signaling pathways.
    Xu Y; Han YF; Zhu SJ; Dong JD; Ye B
    Oncol Rep; 2017 Nov; 38(5):3085-3093. PubMed ID: 28901486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Berberine could inhibit thyroid carcinoma cells by inducing mitochondrial apoptosis, G0/G1 cell cycle arrest and suppressing migration via PI3K-AKT and MAPK signaling pathways.
    Li L; Wang X; Sharvan R; Gao J; Qu S
    Biomed Pharmacother; 2017 Nov; 95():1225-1231. PubMed ID: 28931215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic inhibition of thyroid cancer by suppressing MAPK/PI3K/AKT pathways.
    Kandil E; Tsumagari K; Ma J; Abd Elmageed ZY; Li X; Slakey D; Mondal D; Abdel-Mageed AB
    J Surg Res; 2013 Oct; 184(2):898-906. PubMed ID: 23602735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGF-induced cell migration is mediated by ERK and PI3K/AKT pathways in cultured human lens epithelial cells.
    Jiang Q; Zhou C; Bi Z; Wan Y
    J Ocul Pharmacol Ther; 2006 Apr; 22(2):93-102. PubMed ID: 16722795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression and overactivation of Akt in thyroid carcinoma.
    Ringel MD; Hayre N; Saito J; Saunier B; Schuppert F; Burch H; Bernet V; Burman KD; Kohn LD; Saji M
    Cancer Res; 2001 Aug; 61(16):6105-11. PubMed ID: 11507060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
    Ma Y; Qin H; Cui Y
    Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRLF1 promotes malignant phenotypes of papillary thyroid carcinoma by activating the MAPK/ERK and PI3K/AKT pathways.
    Yu ST; Zhong Q; Chen RH; Han P; Li SB; Zhang H; Yuan L; Xia TL; Zeng MS; Huang XM
    Cell Death Dis; 2018 Mar; 9(3):371. PubMed ID: 29515111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase Akt activity in human thyroid tumors.
    Guda BB; Pushkarev VV; Zhuravel OV; Kovalenko AY; Pushkarev VM; Taraschenko YM; Tronko MD
    Ukr Biochem J; 2016; 88(5):90-5. PubMed ID: 29235817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular taurine induces angiogenesis by activating ERK-, Akt-, and FAK-dependent signal pathways.
    Baek YY; Cho DH; Choe J; Lee H; Jeoung D; Ha KS; Won MH; Kwon YG; Kim YM
    Eur J Pharmacol; 2012 Jan; 674(2-3):188-99. PubMed ID: 22130357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HPIP promotes thyroid cancer cell growth, migration and EMT through activating PI3K/AKT signaling pathway.
    Wang SC; Chai DS; Chen CB; Wang ZY; Wang L
    Biomed Pharmacother; 2015 Oct; 75():33-9. PubMed ID: 26463629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of uPAR inhibits migration, invasion, proliferation, FAK/PI3K/Akt signaling and induces senescence in papillary thyroid carcinoma cells.
    Nowicki TS; Zhao H; Darzynkiewicz Z; Moscatello A; Shin E; Schantz S; Tiwari RK; Geliebter J
    Cell Cycle; 2011 Jan; 10(1):100-7. PubMed ID: 21191179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LPAR5 promotes thyroid carcinoma cell proliferation and migration by activating class IA PI3K catalytic subunit p110β.
    Zhao WJ; Zhu LL; Yang WQ; Xu SJ; Chen J; Ding XF; Liang Y; Chen G
    Cancer Sci; 2021 Apr; 112(4):1624-1632. PubMed ID: 33540491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.